NanoString Technologies Inc (NASDAQ:NSTG) has been given an average recommendation of “Hold” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $16.00.
NSTG has been the subject of several research reports. Zacks Investment Research upgraded NanoString Technologies from a “hold” rating to a “buy” rating and set a $8.25 price objective for the company in a research note on Wednesday, January 3rd. ValuEngine lowered NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, February 2nd. Finally, Robert W. Baird reiterated a “buy” rating and set a $14.00 price objective on shares of NanoString Technologies in a research note on Tuesday, October 24th.
NanoString Technologies (NASDAQ NSTG) traded up $0.21 during trading hours on Wednesday, reaching $7.00. The company’s stock had a trading volume of 189,912 shares, compared to its average volume of 130,669. NanoString Technologies has a 52 week low of $6.31 and a 52 week high of $20.70. The company has a current ratio of 3.35, a quick ratio of 2.89 and a debt-to-equity ratio of 1.08. The stock has a market cap of $172.35, a price-to-earnings ratio of -3.38 and a beta of 0.78.
TRADEMARK VIOLATION WARNING: “Brokerages Set NanoString Technologies Inc (NSTG) Price Target at $16.00” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://stocknewstimes.com/2018/02/24/brokerages-set-nanostring-technologies-inc-nstg-price-target-at-16-00.html.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.